Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

NCT00409617 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

945

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

BIOLOGICAL: adalimumab
BIOLOGICAL: adalimumab

Sponsor

Abbott